Related Experiment Video
Updated: Jul 3, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Orally administered levofloxacin as prophylaxis against pacemaker infection
Natsumi Morito1, Yoshio Yamanouchi, Sunao Kodama
1Department of Cardiology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Oral levofloxacin (LVFX) effectively prevents pacemaker infections, matching intravenous cefazolin efficacy. This study shows oral antibiotics are a viable option for post-pacemaker surgery infection prophylaxis.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Prophylaxis
Background:
- Pacemaker implantation is associated with infection risk despite sterile procedures.
- Antibiotic prophylaxis, either intravenous or oral, is considered to mitigate this risk.
- Evaluating the efficacy of oral levofloxacin (LVFX) for preventing pacemaker infections is crucial.
Purpose of the Study:
- To assess the effectiveness of orally administered levofloxacin (LVFX) in preventing infections after permanent pacemaker implantation.
- To compare the efficacy of oral LVFX with intravenous cefazolin for surgical site infection prophylaxis.
Main Methods:
- A study involving 39 patients undergoing pacemaker implantation or replacement.
- Group 1 (19 patients) received intravenous cefazolin post-surgery.
- Group 2 (20 patients) received oral levofloxacin (LVFX) pre- and post-surgery.
Main Results:
- Inflammatory markers (white blood cell count and C-reactive protein) showed similar trends in both groups.
- No significant difference in inflammatory responses was observed between patients receiving oral LVFX and intravenous cefazolin.
- This suggests comparable prophylactic effects regarding infection indicators.
Conclusions:
- Orally administered levofloxacin (LVFX) is as successful as intravenously administered cefazolin in preventing pacemaker infections.
- Oral LVFX represents a viable and effective prophylactic strategy for patients undergoing pacemaker implantation.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Inhibitors of Bacterial DNA Synthesis
Endocarditis I: Introduction
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...